Wakamoto Pharmaceutical Co.,Ltd. (TYO:4512)

Japan flag Japan · Delayed Price · Currency is JPY
270.00
-2.00 (-0.74%)
Aug 4, 2026, 1:28 PM JST
Market Cap9.46B -8.4%
Revenue (ttm)9.43B -2.5%
Net Income-222.00M
EPS-6.38
Shares Out 34.79M
PE Ration/a
Forward PEn/a
Dividend3.00 (1.11%)
Ex-Dividend DateMar 30, 2026
Volume21,000
Open270.00
Previous Close272.00
Day's Range268.00 - 271.00
52-Week Range240.00 - 380.00
Beta0.43
Analystsn/a
Price Targetn/a
Earnings DateAug 5, 2026

About Wakamoto Pharmaceutical

Wakamoto Pharmaceutical Co.,Ltd. is engaged in the manufacture and sale of pharmaceuticals, medical devices, and health food in Japan. It operates through four segments: Pharmaceutical Business, Healthcare Business, Global Business, and Real Estate Leasing Business. The company offers Strong and Granule Wakamoto, gastrointestinal drugs for digestion, intestinal regulation, and nutritional supplementation, as well as Wakamoto Intestinal Remedy drug. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral ... [Read more]

Sector Healthcare
Founded 1929
Employees 403
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4512
Full Company Profile

Financial Performance

In fiscal year 2012, Wakamoto Pharmaceutical's revenue was 9.43 billion, a decrease of -2.45% compared to the previous year's 9.67 billion. Losses were -222.00 million, -47.76% less than in 2011.

Financial Statements